First in patient study of anti-GM-CSF monoclonal antibody (MOR103) in active rheumatoid arthritis: Results of a phase 1b/2a randomized, double-blind, placebo-controlled trial.

F. Behrens, Mikkel Østergaard, R. Stoilov, P. Wiland, T.W. Huizinga, V.Y. Berenfus, P.-P. Tak, S. Vladeva, J. Rech, A. Rubbert-Roth, M. Korkosz, D. Rekalov, I.A. Zupanets, B.J. Ejbjerg, J. Geiseler, J. Fresenius, R.P. Korolkiewicz, A.J. Schottelius, H. Burkhardt

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

    OriginalsprogEngelsk
    TidsskriftArthritis & Rheumatism
    ISSN0004-3591
    DOI
    StatusUdgivet - 2012

    Bibliografisk note

    Late-breaking abstract L11

    Citationsformater